Related Experiment Video
Updated: Mar 21, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55
Aitzkoa Lopez de Lapuente1, Ana Feliú2, Nerea Ugidos1
1Neurogenomiks Laboratory, University of the Basque Country (University of Pais Vasco/Euskal Herriko University), 48170 Zamudio, Spain; Achucarro Basque Center for Neuroscience, 48170 Zamudio, Spain;
The ANKRD55 gene variant rs6859219 is linked to multiple sclerosis risk. This study shows ANKRD55 is expressed in immune cells and its levels are affected by the risk variant, suggesting a role in neuroinflammation.
Area of Science:
- Neuroimmunology
- Genetics
- Molecular Biology
Background:
- Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system.
- An intronic variant, rs6859219, in the ANKRD55 gene is a known genetic risk factor for MS.
- The biological mechanisms linking rs6859219 to MS pathogenesis remain unclear.
Purpose of the Study:
- To investigate the expression patterns of ANKRD55 in human and murine cells.
- To determine the relationship between the MS risk variant rs6859219 and ANKRD55 expression.
- To explore the role of ANKRD55 in neuroinflammation and experimental autoimmune encephalomyelitis (EAE).
Main Methods:
- Characterization of ANKRD55 transcript variants in human peripheral blood mononuclear cells (PBMCs) and various cell lines.
- Quantitative analysis of ANKRD55 expression in relation to rs6859219 genotype.
- Immunofluorescence and flow cytometry to assess ANKRD55 protein localization and expression in human and murine cells, including during EAE.
- Analysis of ANKRD55 expression in response to inflammatory stimuli.
Main Results:
- Three ANKRD55 transcript variants (001, 005, 007) were detected in human PBMCs and CD4(+) T cells, with variant 007 being the most abundant.
- The rs6859219 variant acts as a cis-expression quantitative trait locus (eQTL), significantly associated with ANKRD55 transcript levels in PBMCs and CD4(+) T cells.
- Risk allele homozygotes showed over fourfold higher ANKRD55 transcript levels compared to protective allele homozygotes.
- ANKRD55 protein isoforms were localized to the nucleus in CD4(+) T cells and other cell lines.
- ANKRD55 was expressed in murine neurons and microglia, induced by inflammatory stimuli, and elevated in EAE.
- CD4(+) T cells and monocytes infiltrating the CNS in EAE mice showed increased ANKRD55 expression.
Conclusions:
- ANKRD55 expression is cell-type specific, predominantly in CD4(+) T cells.
- The MS risk variant rs6859219 influences ANKRD55 expression levels in a cis-regulatory manner.
- These findings support a significant role for ANKRD55 in the pathogenesis of multiple sclerosis and neuroinflammation.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Atherosclerosis I: Introduction